共 45 条
[1]
Horowitz B(2015)Epidemiology of hypertension in CKD Adv Chronic Kidney Dis 22 88-95
[2]
Miskulin D(2001)Prevalence of hypertension in renal disease Nephrol Dial Transplant 16 70-3
[3]
Zager P(2003)In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5 Drug Metab Dispos 31 938-44
[4]
Ridao N(2016)Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America Clin Infect Dis 63 e1-60
[5]
Luño J(2009)Hypotension due to the drug interaction of voriconazole with eplerenone and nifedipine Eur J Clin Pharmacol 65 323-4
[6]
García de Vinuesa S(2011)The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers CMAJ 183 303-7
[7]
Gómez F(2012)Risk of hypotension with concomitant use of calcium-channel blockers and macrolide antibiotics Am J Health Syst Pharm 69 1038-43
[8]
Tejedor A(2017)Acute Kidney Injury from Excessive Potentiation of Calcium-channel Blocker via Synergistic CYP3A4 Inhibition by Clarithromycin Plus Voriconazole Intern Med 56 1687-90
[9]
Valderrábano F(2014)Iatrogenic cushing syndrome secondary to a probable interaction between voriconazole and budesonide Pharmacotherapy 34 e116-9-63
[10]
Patki KC(2017)Adrenal Insufficiency With Voriconazole and Inhaled/Intranasal Corticosteroids: Case Report and Systematic Review J Pharm Pract 30 459-81